Vaccine for B-cell malignancies
US6312718A · kind A · utility
7Cited by
2References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 1998 |
| Grant date | Nov 6, 2001 |
| Priority date | — |
| Expiry date | Oct 27, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55511
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A vaccine comprising a liposome preparation including at least one B-cell malignancy-associated antigen, IL-2, alone or in combination with at least one other cytokine, and at least one type of lipid molecule, is useful in a method of inducing humoral and cellular immune responses against malignant B-cells in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.